Literature DB >> 11768265

Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of reflux esophagitis in Western Sydney between 1990 and 1998.

H H Xia1, N Phung, E Altiparmak, A Berry, M Matheson, N J Talley.   

Abstract

We aimed to determine if changes in the patterns of upper gastrointestinal diseases at endoscopy have occurred over the past decade. Retrospectively, 917 consecutive patients were selected based on upper endoscopy between June 1 and August 31, in 1990 (n = 217), 1994 (n = 270), and 1998 (n = 430). Demographic, clinical, endoscopic, and histological information were extracted from the medical records on a standardized case record form. Over the eight-year period, follow-up of peptic ulcer (15%, 5%, and 5%, respectively, in 1990, 1994, and 1998, df = 2, P < 0.001), bleeding (22%, 14%, and 13%, P = 0.008), and nausea/vomiting (15%, 16%, and 10%, df = 2, P = 0.003) had become less frequent, but reflux (21%, 19%, and 34%, df = 2, P < 0.001) and dyspepsia (24%, 43%, and 32%, df = 2, P < 0.001) more frequent indications for upper endoscopy. The prevalence of peptic ulcer disease decreased (22%, 15%, and 13%, df = 2, P = 0.025), but the prevalence of reflux esophagitis increased significantly (29%, 30%, and 39%, df = 2, P = 0.010). The prevalence of both the use of nonsteroidal antiinflammatory drugs (NSAIDs) (18%, 20%, and 11%, respectively, in 1990, 1994, and 1998, df = 2, P = 0.004) and H. pylori infection (39% in 1994 and 30% in 1998, df = 1, P = 0.032) decreased. Overall, NSAID use was independently associated with gastric ulcers (OR = 2.39, 95% CI 1.21-4.73, chi2 = 6.31, df = 1, P = 0.012), but not esophagitis. H. pylori infection was independently associated with duodenal ulcers (OR = 4.74, 95% CI 2.30-9.77, chi2 = 17.8, df = 1, P < 0.001), histologically chronic (OR = 166.8, 95% CI 76.1-365.4, chi2 = 313.0, df = 1, P < 0.001) and active (OR = 30.1, 95% CI 17.0-53.5, chi2 = 189.7, df = 1, P < 0.001) gastritis and lymphoid aggregates (OR = 5.49, 95% CI 3.02-9.97, chi2 = 36.3, df = 1, P < 0.001). In conclusion, the prevalence of peptic ulcer disease appears to have been decreasing, whereas reflux esophagitis has been increasing over the past decade in Western Sydney. The decreased use of NSAIDs and decline of H. pylori infection have likely both contributed to the reduction of peptic ulcer disease, but the increase in reflux esophagitis remains to be fully explained.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11768265     DOI: 10.1023/a:1012731614075

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  38 in total

1.  Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

Authors:  G R Locke; N J Talley; S L Fett; A R Zinsmeister; L J Melton
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

Review 2.  Helicobacter pylori eradication in patients with non-ulcer dyspepsia.

Authors:  H H Xia; N J Talley
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

Review 3.  Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications.

Authors:  H H Xia; N J Talley
Journal:  Am J Gastroenterol       Date:  1997-10       Impact factor: 10.864

4.  Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: a study from the East.

Authors:  J C Wu; J J Sung; E K Ng; M Y Go; W B Chan; F K Chan; W K Leung; C L Choi; S C Chung
Journal:  Am J Gastroenterol       Date:  1999-07       Impact factor: 10.864

Review 5.  Helicobacter pylori infection, reflux esophagitis, and atrophic gastritis: an unexplored triangle.

Authors:  H H Xia; N J Talley
Journal:  Am J Gastroenterol       Date:  1998-03       Impact factor: 10.864

6.  High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis.

Authors:  H Hamada; K Haruma; M Mihara; T Kamada; M Yoshihara; K Sumii; G Kajiyama; M Kawanishi
Journal:  Aliment Pharmacol Ther       Date:  2000-06       Impact factor: 8.171

7.  Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis.

Authors:  G D Eslick; L L Lim; J E Byles; H H Xia; N J Talley
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

Review 8.  Helicobacter pylori and gastroesophageal reflux disease.

Authors:  D C Metz; J A Kroser
Journal:  Gastroenterol Clin North Am       Date:  1999-12       Impact factor: 3.806

9.  Interobserver variation in the endoscopic diagnosis of reflux esophagitis.

Authors:  P Bytzer; T Havelund; J M Hansen
Journal:  Scand J Gastroenterol       Date:  1993-02       Impact factor: 2.423

10.  Rapid urease test in the management of Campylobacter pyloridis-associated gastritis.

Authors:  B J Marshall; J R Warren; G J Francis; S R Langton; C S Goodwin; E D Blincow
Journal:  Am J Gastroenterol       Date:  1987-03       Impact factor: 10.864

View more
  8 in total

1.  Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? A 10 years' endoscopical survey.

Authors:  Giorgio Nervi; Stefania Liatopoulou; Lucas-Giovanni Cavallaro; Alessandro Gnocchi; Nadia Dal-Bo; Massimo Rugge; Veronica Iori; Giulia-Martina Cavestro; Marta Maino; Giancarlo Colla; Angelo Franze; Francesco Di Mario
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

2.  Different peptic ulcer bleeding risk in chronic kidney disease and end-stage renal disease patients receiving different dialysis.

Authors:  Kuang-Wei Huang; Hsin-Bang Leu; Jiing-Chyuan Luo; Wan-Leong Chan; Ming-Chih Hou; Han-Chieh Lin; Fa-Yauh Lee; Yi-Chun Kuan
Journal:  Dig Dis Sci       Date:  2013-12-08       Impact factor: 3.199

3.  Epidemiology of Helicobacter pylori in Australia: a scoping review.

Authors:  Jillian Congedi; Craig Williams; Katherine L Baldock
Journal:  PeerJ       Date:  2022-05-31       Impact factor: 3.061

4.  Acute Upper Gastrointestinal Bleeding: Less Severe Bleeding in More Frail and Older Patients, Comparison Between Two Time Periods Fifteen Years Apart.

Authors:  Christos Sotiropoulos; Konstantinos Papantoniou; Efthimios Tsounis; Georgia Diamantopoulou; Christos Konstantakis; Georgios Theocharis; Christos Triantos; Konstantinos Thomopoulos
Journal:  Gastroenterology Res       Date:  2022-06-22

5.  Has peptic ulcer disease changed during the past ten years in Korea? A prospective multi-center study.

Authors:  Hyun Joo Jang; Min Ho Choi; Woon Geon Shin; Kyung Ho Kim; Yong Woo Chung; Kyoung Oh Kim; Cheol Hee Park; Il Hyun Baek; Kwang Ho Baik; Sea Hyub Kae; Hak Yang Kim
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

6.  The changing pattern of upper gastrointestinal disorders by endoscopy: data of the last 40 years.

Authors:  Erkan Caglar; Birol Baysal; Ahmet Dobrucalı
Journal:  Diagn Ther Endosc       Date:  2014-09-08

7.  Long-term Trends in Primary Sites of Gastric Adenocarcinoma in Japan and the United States.

Authors:  Michitaka Honda; Sandra L Wong; Mark A Healy; Toshifusa Nakajima; Masayuki Watanabe; Shingo Fukuma; Shunichi Fukuhara; John Z Ayanian
Journal:  J Cancer       Date:  2017-07-05       Impact factor: 4.207

8.  Downward trend in the prevalence of Helicobacter pylori infections and corresponding frequent upper gastrointestinal diseases profile changes in Southeastern China between 2003 and 2012.

Authors:  Jian-Xia Jiang; Qing Liu; Xin-Yi Mao; Hai-Han Zhang; Guo-Xin Zhang; Shun-Fu Xu
Journal:  Springerplus       Date:  2016-09-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.